Nancy Ryan Gray

Business address
C/O Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Boulevard, Ste 110, San Diego, CA, 92121
Top holdings (ownership)
LGND
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Nancy Ryan Gray has filed 17 SEC EDGAR filings since 22 Aug 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 12 Nov 2025 07 Nov 2025 001-33093
144 Open Document Open Filing 07 Nov 2025
4 Open Document Open Filing PRIMARY DOCUMENT 10 Jun 2025 06 Jun 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 18 Jun 2024 14 Jun 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 17 May 2024 09 May 2024 001-33093
144 Open Document Open Filing 09 May 2024
144 Open Document Open Filing 28 Feb 2024
4 Open Document Open Filing PRIMARY DOCUMENT 13 Jun 2023 09 Jun 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 27 Dec 2022 22 Dec 2022 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 13 Jun 2022 10 Jun 2022 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 07 Jun 2021 04 Jun 2021 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jun 2020 10 Jun 2020 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 07 Jun 2019 06 Jun 2019 001-33093
4/A Open Document Open Filing PRIMARY DOCUMENT 03 Jul 2018 19 Jun 2018 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 21 Jun 2018 19 Jun 2018 001-33093
4 Open Document Open Filing FORM 4 22 Aug 2017 18 Aug 2017 001-33093
3 Open Document Open Filing FORM 3 22 Aug 2017 18 Aug 2017 001-33093